Corticosteroids

Go to algorithm

BUDESONIDE

Therapy notes

Formulation and dosage details

Formulation:

Orodispersible tablets 1mg (specialist initiation: for eosinophilic oesophagitis)

Dosage:

Indication: SMC2158: Treatment of eosinophilic oesophagitis (EoE) in adults (older than 18 years of age).
SMC restriction: For patients unsuccessfully treated with proton pump inhibitors.

Formulation and dosage details

Formulation:

Rectal foam 2mg/dose

Dosage:

As per SMC 409/07

View drug information

PREDNISOLONE

Therapy notes

MHRA advice: Drug-name confusion: reminder to be vigilant for potential errors (January 2018) (www.gov.uk).

  • Note:  Use standard prednisolone tablets instead of enteric-coated tablets in inflammatory bowel disease.
  • Note: Consider co-prescribing bone protection for the duration of steroid therapy, refer to Drugs affecting bone metabolism.

Formulation

Tablets 1mg, 5mg

Formulation

Soluble tablets 5mg

Formulation

Suppositories 5mg

Last reviewed: 24 June 2021